Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
More than 800 flights canceled as FAA cuts traffic at 40 major airports. Here's what to know.07.11.2025 - 2The Best Internet Mastering Stages for Expertise Improvement06.07.2023
- 3Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny31.12.2025
- 4Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground22.11.2025
- 5Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World31.12.2025
- Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza
- Ukraine demands army of 800,000 under peace plan
- Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
- 6 Fun Urban areas For Seniors To Travel
- She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
- Bayer reports positive results for blood thinner after 2023 setback
- Farmers call for French blockades over cow disease cull
